National Asset Management Inc. Decreases Position in SPDR S&P Biotech ETF (XBI)

National Asset Management Inc. cut its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 11,958 shares of the exchange traded fund’s stock after selling 469 shares during the period. National Asset Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,083,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Cranbrook Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $26,000. Gradient Investments LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $27,000. Quattro Financial Advisors LLC lifted its position in shares of SPDR S&P Biotech ETF by 49.6% in the fourth quarter. Quattro Financial Advisors LLC now owns 374 shares of the exchange traded fund’s stock valued at $31,000 after buying an additional 124 shares during the last quarter. Lehman & Derafelo Financial Resources LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $32,000. Finally, Covington Capital Management acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $41,000.

XBI opened at $83.27 on Wednesday. SPDR S&P Biotech ETF has a 12-month low of $64.38 and a 12-month high of $101.55.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/05/22/national-asset-management-inc-decreases-position-in-spdr-sp-biotech-etf-xbi.html.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading: CBOE Russell 2000® Volatility Index

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.